Moderna, Webull, Bitmine Immersion, Strategy and Merck: Why These 5 Stocks Are on Investors' Radars Today
In brief
Moderna’s Phase‑3 win could pivot the company toward oncology, while Webull, Bitmine, Strategy, and Merck all benefited from strong earnings or market sentiment, driving significant intraday gains.